Last updated on March 2017

Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)


Brief description of study

Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)

Detailed Study Description

The aim of the study is to investigate the longterm impact on cardiovascular morbidity, mortality and renal function of treatment with linagliptin in a selected population of patients with T2DM and to compare outcomes against placebo, on a background of standard of care.

Clinical Study Identifier: TX148065

Contact Investigators or Research Sites near you

Start Over

Patient Recruitment

Cedar Crosse Research Center
Chicago, IL USA
  Connect »